Point72 Asset Management, L.P. - 31 Dec 2025 SCHEDULE 13G/A Report for Cidara Therapeutics, Inc. Common Stock, par value $0.0001 per share (CDTX)

Filing Manager
Point72 Asset Management, L.P.
Reporting Manager
Point72 Asset Management, L.P.
Security
Cidara Therapeutics, Inc. Common Stock, par value $0.0001 per share
Symbol
CDTX
Shares outstanding
32,142,857 shares
Disclosed Ownership
450,000 shares
Ownership
1.4%
Form type
SCHEDULE 13G/A
Filing time
17 Feb 2026, 16:32:06 UTC
Date of event
31 Dec 2025
Previous filing
14 Nov 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Point72 Asset Management, L.P. disclosed 1.4% ownership in Cidara Therapeutics, Inc. Common Stock, par value $0.0001 per share (CDTX) on 31 Dec 2025."

Quick Takeaways

  • Point72 Asset Management, L.P. filed SCHEDULE 13G/A for Cidara Therapeutics, Inc. Common Stock, par value $0.0001 per share (CDTX).
  • Disclosed ownership: 1.4%.
  • Date of event: 31 Dec 2025.

What Changed

  • Previous schedule filing date: 14 Nov 2025.
  • Current filing was accepted on 17 Feb 2026, 16:32.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Point72 Asset Management, L.P. 1.4% 450,000 0 450,000 /s/ Jason M. Colombo Jason M. Colombo, Authorized Person
Point72 Capital Advisors, Inc. 1.4% 450,000 0 450,000 /s/ Jason M. Colombo Jason M. Colombo, Authorized Person
Steven A. Cohen 1.4% 450,000 0 450,000 /s/ Jason M. Colombo Jason M. Colombo, Authorized Person

Sponsored